Krilogy Financial’s ARK Genomic Revolution ETF ARKG Stock Holding History

Krilogy Financial’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-195,220	Closed	-$5.81M	–	927
2025 Q3	$5.81M	Buy	+195,220	New	+$4.93M	0.22%	72
2025 Q1	–	Sell	-117,276	Closed	-$2.76M	–	223
2024 Q4	$2.76M	Sell	117,276 -19,641	-14%	-$483K	0.18%	105
2024 Q3	$3.51M	Buy	+136,917	New	+$3.49M	0.24%	91

Other funds holding ARKG

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Krilogy Financial's ARKG Position: Q4 2025 in Review

Krilogy Financial sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2025, closing a stake of 195,220 shares — an estimated $5.81M sold.

Krilogy Financial first reported a position in ARKG in Q3 2024 and held it in 3 quarters. The position peaked at $5.81M in Q3 2025. 238 funds tracked by Wall St. Rank hold ARKG as of Q4 2025.

Krilogy Financial reported no remaining ARK Genomic Revolution ETF position as of Q4 2025 after selling out during the quarter.
Krilogy Financial sold 195,220 ARK Genomic Revolution ETF shares in Q4 2025, an estimated $5.81M.
Krilogy Financial first reported a position in ARK Genomic Revolution ETF in Q3 2024 and held it in 3 quarters.
Krilogy Financial's ARK Genomic Revolution ETF position peaked at $5.81M in Q3 2025.
238 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2025.

Based on Krilogy Financial's 13F filing for Q4 2025, filed 27 Jan 2026.